Probiotic Formula Ameliorates Renal Dysfunction Indicators, Glycemic Levels, and Blood Pressure in a Diabetic Nephropathy Mouse Model
Nutrients · 19.06.2023 · 15 (12) · 2803
DOI: 10.3390/nu15122803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 19.06.2023. Verfasst von Yi-Wei Kuo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Design, Glac Biotech Co., Ltd., Tainan 744, Taiwan. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Probiotics, Renal Insufficiency, Chronic, Diabetes Mellitus. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Glac Biotech Co., Ltd..
Abstract (Originalsprache)
One-third of patients with end-stage chronic kidney disease (CKD) experience diabetic nephropathy (DN), which worsens the progression of renal dysfunction. However, preventive measures for DN are lacking. Lactobacillus acidophilus TYCA06, Bifidobacterium longum subsp. infantis BLI-02, and Bifidobacterium bifidum VDD088 probiotic strains have been demonstrated to delay CKD progression. This study evaluated their biological functions to stabilize blood-glucose fluctuations and delay the deterioration of renal function. The db/db mice were used to establish a DN animal model. This was supplemented with 5.125 × 109 CFU/kg/day (high dose) or 1.025 × 109 CFU/kg/day (low dose) mixed with probiotics containing TYCA06, BLI-02, and VDD088 for 8 weeks. Blood urea nitrogen (BUN), serum creatinine, blood glucose, and urine protein were analyzed. Possible mechanisms underlying the alleviation of DN symptoms by probiotic strains were evaluated through in vitro tests. Animal experiments revealed that BUN, serum creatinine, and blood glucose upon probiotic administration were significantly lower than in the control group. The rate of change of urine protein decreased significantly, and blood pressure, glucose tolerance, and renal fibrosis were improved. In vitro testing indicated that TYCA06 and BLI-02 significantly increased acetic acid concentration. TYCA06, BLI-02, and VDD088 were associated with better antioxidation, anti-inflammation, and glucose consumption activities relative to the control. A combination of the probiotics TYCA06, BLI-02, and VDD088 attenuated renal function deterioration and improved blood-glucose fluctuation in a diabetes-induced CKD mouse model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Research and Design, Glac Biotech Co., Ltd., Tainan 744, Taiwan.
- Center of Allergy, Immunology, and Microbiome (AIM), China Medical University Children's Hospital, Taichung 404, Taiwan.
- Allergy and Clinical Immunology Research (ACIR) Center, National Cheng Kung University, Tainan 701, Taiwan.
- Department of Allergy and Immunology, China Medical University Children's Hospital, Taichung 404, Taiwan.
ORCID-Profile: Yi-Wei Kuo, Jia-Hung Lin, Hui-Shan Wang, Yu-Chieh Hsu, Ko-Chiang Hsia
Förderung
- Glac Biotech Co., Ltd.
Zitieren
APA
Kuo, Y. W., Huang, Y. Y., Tsai, S. Y., Wang, J. Y., Lin, J. H., Syu, Z. J., Wang, H. S., Hsu, Y. C., Chen, J. F., Hsia, K. C., & Ho, H. H. (2023). Probiotic Formula Ameliorates Renal Dysfunction Indicators, Glycemic Levels, and Blood Pressure in a Diabetic Nephropathy Mouse Model. Nutrients, 15(12), 2803. https://doi.org/10.3390/nu15122803
Vancouver
Kuo YW, Huang YY, Tsai SY, Wang JY, Lin JH, Syu ZJ, et al. Probiotic Formula Ameliorates Renal Dysfunction Indicators, Glycemic Levels, and Blood Pressure in a Diabetic Nephropathy Mouse Model. Nutrients. 2023;15(12):2803. doi:10.3390/nu15122803
BibTeX
@article{Kuo2023,
author = {Kuo, Yi-Wei and Huang, Yen-Yu and Tsai, Shin-Yu and Wang, Jiu-Yao and Lin, Jia-Hung and Syu, Zun-Jie and Wang, Hui-Shan and Hsu, Yu-Chieh and Chen, Jui-Fen and Hsia, Ko-Chiang and Ho, Hsieh-Hsun},
title = {Probiotic Formula Ameliorates Renal Dysfunction Indicators, Glycemic Levels, and Blood Pressure in a Diabetic Nephropathy Mouse Model},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {12},
pages = {2803},
doi = {10.3390/nu15122803}
}
EUVIMED